medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 6

<< Back Next >>

Med Int Mex 2012; 28 (6)

Soft tissue infection by Stenotrophomas maltophilia in a patient with aplastic anemia

Carrillo ER, Martínez LJF, Mendoza GJG
Full text How to cite this article

Language: Spanish
References: 14
Page: 621-625
PDF size: 226.45 Kb.


Key words:

Stenotrophomonas maltophilia, soft tissue infection, aplastic anemia, neutropenia.

ABSTRACT

Stenotrophomonas maltophilia is an aerobic gramnegative rod. It causes infection in immunosuppressed hosts, specially those who are neutropaenic, on chemotherapy and broad spectrum antibiotics. S. maltophilia causes principally bacteremias or ventilator associated pneumonia. Skin and soft tissue infections secondary to S. maltophilia are uncommon but are becoming increasingly recognized entity in patients with cancer or hematological diseases. The clinical spectrum ranges from cellulitis to mucocutaneous and metastatic nodular skin lesions. We describe the case of a patient with severe neutropenia secondary to aplastic anemia who developed cellulitis of the left foot by S. maltophilia.


REFERENCES

  1. Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 2007 ; 45:1602–1609.

  2. Looney WJ, Narita M, Mühlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 2009; 9: 312–323.

  3. Matejkovás ON. Stenotrophomonas maltophilia: Significant Contemporary Hospital Pathogen – review. Folia Microbiol 2010; 55: 286–294.

  4. Abdulhak AB, Zimmerman V, Al Beirouti B, Baddour L, Tleyjeh. Stenotrophomonas maltophilia infections of intact skin: a systematic review of the literature. Diagn Microbiol Infect Dis 2009; 63: 330–333.

  5. Avison MB, Higgins CS, Von Heldreich CJ, Bennet PM, Walsh TR. Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001; 45:413–419.

  6. Kwa A, Low JG, Lim TP, Leow PC, Kurup A,Tam VH. Independent Predictors for Mortality in Patients with Positive Stenotrophomonas maltophilia Cultures. Ann Acad Med Singapore 2008;37:826-830.

  7. Gutiérrez CA, Reyes E, Corona F. Stenotrophomonas maltophilia, una bacteria multirresistente. Rev Asoc Mex Med Crit y Ter Int 2007;21:91-94

  8. Wan-Yee T, Mei-Yoke C, Ching-Mei L, Chia-Yin C. Skin Manifestation of Stenotrophomonas maltophilia Infection – A Case Report and Review Article. Ann Acad Med Singapore 2006;35:897-900.

  9. Denton M, Kerr K. Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia. Clin. Microbio. Rer 1998;11: 57–80.

  10. Del Toro, Rodríguez J, Martínez L, Pascual A, Pérez R, Perea EJ, et al. Epidemiology, clinical features and prognosis of infections due to Stenotrophomonas maltophilia. Enferm Infecc Microbiol Clin 2006;24:4-9.

  11. Mukhopadhyay C, Bhargava A, Ayyagari A. Novel Nosocomial Infections by Stenotrophomonas maltophilia: First Reported Case from Lucknow, North India. J. Clin Microbiol 2003, 4:3989-3990

  12. Chrystal JL, Fernández AV. Stenotrophomonas maltophilia. Rev Chil Infect 2006; 23: 247-248

  13. Nicodemo AC, García JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 2007; 26:229–237.

  14. Jones RN, Sader HS, Beach ML.Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). Int J Antimicrob Agents 2003; 22: 551-556.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2012;28